CCN2 and metabolic dysfunction-associated steatohepatitis: Finally, our data show that CCN2 production is central to the fibrotic response in NASH and that elevated hepatic CCN2 can drive more pronounced aspects of NASH fibrosis, highlighting its potential as a target by which NASH fibrosis could be suppressed and thus reducing the associated risk of increased disease severity and death.